Sophies Hope Foundation
Fund Raising, 23 Briarcliff Dr, Hopkinton, Massachusetts, 02215, United States, 1-10 Employees
Phone Number: +15*********
Who is SOPHIES HOPE FOUNDATION
Sophies Hope Foundations primary focus is on finding a cure for Glycogen Storage Disease Type 1b. We are a patient advocacy organization fighting to push science to create better outcomes...
Read More
- Headquarters: 23 Briarcliff Dr, Hopkinton, Massachusetts, 02215, United States
- Date Founded: 2020
- Employees: 1-10
- Revenue: $1 Billion and Over
- Active Tech Stack: See technologies
Industry: Fund Raising
SIC Code: 8011 | NAICS Code: 621111 | Show More
Does something look wrong? Fix it. | View contact records from SOPHIES HOPE FOUNDATION
Sophies Hope Foundation Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Sophies Hope Foundation
Answer: Sophies Hope Foundation's headquarters are located at 23 Briarcliff Dr, Hopkinton, Massachusetts, 02215, United States
Answer: Sophies Hope Foundation's phone number is +15*********
Answer: Sophies Hope Foundation's official website is https://sophieshopefoundation.org
Answer: Sophies Hope Foundation's revenue is $1 Billion and Over
Answer: Sophies Hope Foundation's SIC: 8011
Answer: Sophies Hope Foundation's NAICS: 621111
Answer: Sophies Hope Foundation has 1-10 employees
Answer: Sophies Hope Foundation is in Fund Raising
Answer: Sophies Hope Foundation contact info: Phone number: +15********* Website: https://sophieshopefoundation.org
Answer: Sophies Hope Foundations primary focus is on finding a cure for Glycogen Storage Disease Type 1b. We are a patient advocacy organization fighting to push science to create better outcomes for children and adults with GSD1b. We are a volunteer-run 501c3 that was started by Sophies parents, Jamas and Margot LaFreniere, after their daughter Sophie was diagnosed in September of 2019. Our team is an incredible mix of passionate parents, brilliant doctors and scientist, and rare disease advocates. GSD1b is an extremely rare genetic disease in which the body is missing an enzyme to convert glycogen into glucose. A normal liver converts glycogen to glucose to provide energy during periods of fasting. Because the body is missing this enzyme people with GSD1b are at risk for hypoglycemia (low blood sugar) and if not maintained on a very strict diet and scheduled doses of corn starch feedings they are at risk for seizures, coma, and potentially death. She requires corn starch every 4 hours even throughout the night. The scary reality is that we are one missed or faulty alarm away from a possible disaster. GSD1b also causes neutropenia which is a low white blood cell count and makes her more susceptible to infections and impairs her ability to fight infection. The current treatment for neutropenia in GSD1b is a daily injection of the drug filgrastim (a neutrophil growth factor). For Sophie, administering the drug requires a daily injection. Because her liver is not functioning normally, she is also at risk of developing liver tumors and certain intestinal illness later in life. Although treatment is very antiquated and there is no cure today, we have very good reason to believe better treatment and a cure are achievable. We know the science and technology exists and we believe by getting organized and bringing collaboration and strong voice we can bring major advancements to GSD1b. Thank you for joining us on this journey!
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month